LOGIN 
Maximising reimbursement and navigating payer value
GPI can help you adjust your strategy to ensure maximum payer and reimbursement success, from pre-clinical to post launch. We help you reduce risk and make strategic shifts to your TPP along the journey.
- Benefit from early advice. Understand new drugs as they come to market.
- Assess payer value by testing TPP scenarios for each phase of the product journey.
Design pivotal phase IIb/ III clinical trials
Track specific assessment characteristics for each country that influence reimbursement. Design assessments to demonstrate clinical effectiveness.
Maximise the likelihood of reimbursement
Verify the clinical and economic characteristics required to meet payer data requirements. Ensure all essential data and regulatory requirements are met.
Streamline the launch of new products
Improve payer engagement and reimbursement success. Access known payer compensation and restrictions at pack, product and indication level.
Rapidly adapt to market changes
Adjust your market access strategy for each country. Respond immediately to changes in IRP rules and price revisions, and adapt to change in supply chain margins and markups in near real-time.
Experience our
platform
Know your asset’s price potential versus key competitors
Review each price corridor to see where competitive drugs are priced for treatment.
Request a Demo
Optimise reimbursement
See payer value drivers in each market mapped to analogues and comparators. Adjust your TPP scenarios versus analogues and comparators.
Request a Demo
Market insight across 90+ markets
HTA outcomes & drivers across 31+ countries
IRP policies for 60+ countries
5,000 ATCs
What makes GPI unique?
Up to date and comprehensive data from across the globe
GPI gives you rapid analogue analysis and reimbursement information, verified by access to HTA sources. Understand the key payer value drivers across indications in each market.
Model scenario outcomes
Our advanced analytics, deep understanding of payer dynamics, and decades of experience in pricing and market access can inform your strategy. You can test target TPPs and see which profile results in greater payer value.
GPI expertise at every stage
Our market access consultants develop strategies and actionable recommendations, from product due diligence, through to revenue optimisation. We can help you to maximise reimbursement and accelerate your time to market. Just ask.
Understand Payer Value
GPI can help you understand payer value in each market. Maximise reimbursement potential by national, regional and local payers with using assessment characteristics and each competitors perceived value.
Watch our webinar on International Pricing Strategies
Talk to a data expert today and
we’ll help you optimise product value
Our qualified market experts can help you
maximise reimbursement potential
